Clinical Study on the Treatment of Postpartum Anemia With Compound E Jiao Jiang(cEJJ）

Inclusion Criteria: 1. Patients diagnosed with mild or moderate anemia (70g/L≤Hb \< 110g/L) within 1 week postpartum and suitable for oral drug therapy; 2. Age 18-45 years old (including 18 and 45); 3. Those who do not use other iron agents and Chinese medicine/Chinese medicine preparations that have the effect of invigorating qi and nourishing blood during the study; 4. Sign the subject's informed consent voluntarily. Exclusion Criteria: 1. Postpartum hemorrhage and blood transfusion treatment; 2. Those who received intramuscular/intravenous iron therapy or transfused blood products/human blood albumin and other plasma volume dilators within 3 months prior to screening; 3. Patients who have taken blood tonics within 1 week before screening, including other iron preparations and Chinese medicine or Chinese medicine preparations; 4. People with previous blood diseases such as sickle cell anemia, thalassemia, aplastic anemia, megaloblastic anemia; 5. Severe preeclampsia during pregnancy; 6. Abortion occurs in this pregnancy; 7. Patients with a serious digestive disease, cardiovascular disease, immune system disease, or serious mental disorder that the investigator believes may adversely affect the safety of the subject and/or the effectiveness of the investigational drug; 8. Severe hepatic and renal insufficiency (ALT \>2×ULN, aspartate aminotransferase (AST)\>2×ULN, Urea (Urea)/ urea nitrogen (BUN)\>2×ULN, creatinine (Cr)\>1×ULN); 9. Those who have a history of alcohol abuse, drug abuse or drug use before; 10. Allergic to the experimental drug or known ingredient; 11. Participants who had participated in other clinical trials within 3 months before screening; 12. Those who, according to the judgment of the investigator, consider it inappropriate to participate in this clinical trial.